Biography
Dr. Rita Mukhtar specializes in breast surgery and general surgery for urgent conditions. For her patients with breast cancer, she offers expertise in total skin-sparing mastectomies, breast conservation, wire localization surgery (used to show the location of tissue requiring biopsy) and sentinel lymph node biopsy (used to see if cancer has spread).
Dr. Mukhtar's research program focuses on invasive lobular carcinoma, the second most common type of breast cancer. This work is funded by the American Cancer Society and the National Cancer Institute. She teaches medical students and residents, and serves as an Associate Program Director for the UCSF General Surgery Residency.
Dr. Mukhtar's research program focuses on invasive lobular carcinoma, the second most common type of breast cancer. This work is funded by the American Cancer Society and the National Cancer Institute. She teaches medical students and residents, and serves as an Associate Program Director for the UCSF General Surgery Residency.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California | Diversity, Equity, and Inclusion Champion Training | 2018 | |
University of California, San Francisco | M.D. | Medicine | 2006 |
Board Certifications
American Board of Surgery, General Surgery
Clinical Expertise
Breast Surgery
Lumpectomy
Seed and wire localization surgery
Nipple sparing/total skin sparing mastectomy
Sentinel lymph node biopsy
Axillary dissection
Emergency General Surgery
Clinical Trials
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles (NCT03053193)Related Conditions: Breast Cancer| Start Date: | End Date:
- Related Conditions: Breast Cancer| Start Date: | End Date:
- Related Conditions: Breast Cancer| Start Date: | End Date:
- Related Conditions: Breast Cancer, Carcinoma| Start Date: | End Date:
Program Affiliations
Carol Franc Buck Breast Care Center
In the News
October, 27, 2020 | UCSF Department of Surgery
October, 01, 2020 | UCSF Department of Surgery
July, 10, 2020 | UCSF Department of Surgery
Mary Kathryn (Katy) Abel and Dr. Rita Mukhtar Honored with Awards at 2020 Inquiry Symposium Ceremony
June, 04, 2020 | UCSF Department of SurgeryDecember, 11, 2019 | UCSF Breastcare Program
May, 26, 2017 | UCSF Department of Surgery
Research Pathways
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 162
- Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022.| | View in PubMed
- Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.| | View in PubMed
- Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ.| | View in PubMed
- ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial.| | View in PubMed
- ASO Visual Abstract: Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast-Method of Local Recurrence Detection After Breast Conserving Surgery.| | View in PubMed
- ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.| | View in PubMed
- ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.| | View in PubMed
- International survey on invasive lobular breast cancer identifies priority research questions.| | View in PubMed
- Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.| | View in PubMed
- Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.| | View in PubMed
- Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.| | View in PubMed
- ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared to Standard Breast Conserving Surgery for Patients with Invasive Lobular Carcinoma.| | View in PubMed
- Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.| | View in PubMed
- Impact of extent of disease at presentation on oncologic outcomes according to pathologic response to neoadjuvant systemic therapy among participants of the I-SPY2 clinical trial.| | View in PubMed
- The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes.| | View in PubMed
- Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.| | View in PubMed
- I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant amcenestrant +/- abemaciclib +/- letrozole in molecularly selected patients (pts) with HR+ HER2- stage 2/3 breast cancer (BC).| | View in PubMed
- Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.| | View in PubMed
- ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.| | View in PubMed
- Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.| | View in PubMed
- Abstract PO4-02-03: Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2- Invasive Lobular Carcinoma – A FLEX sub study.| | View in PubMed
- Abstract PO5-26-07: Surgery for Invasive Lobular Carcinoma: A Patient Experience Survey from the Lobular Breast Cancer Alliance.| | View in PubMed
- Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.| | View in PubMed
- Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy.| | View in PubMed
- Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.| | View in PubMed
- Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk.| | View in PubMed
- ASO Visual Abstract: Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.| | View in PubMed
- Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.| | View in PubMed
- ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.| | View in PubMed
- Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.| | View in PubMed
- Letter to the Editor of Annals of Surgical Oncology concerning "Is Choosing Wisely Wise for Lobular Carcinoma in Patients over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns".| | View in PubMed
- The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).| | View in PubMed
- 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study.| | View in PubMed
- Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.| | View in PubMed
- Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.| | View in PubMed
- ASO Author Reflections: Menopausal Status Does Not Predict Successful Breast Conservation Surgery After Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma.| | View in PubMed
- Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.| | View in PubMed
- Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.| | View in PubMed
- Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.| | View in PubMed
- The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.| | View in PubMed
- Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.| | View in PubMed
- ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.| | View in PubMed
- Editorial: Contrast mammography-a promising tool for the pre-operative evaluation of lobular breast cancer.| | View in PubMed
- Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.| | View in PubMed
- Metabolic Positron Emission Tomography in Breast Cancer.| | View in PubMed
- Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.| | View in PubMed
- Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-Reply.| | View in PubMed
- Time to Surgery in Breast Cancer-Is Faster Always Better?| | View in PubMed
- 407 Moving from observational studies to a clinical trial: the impact of obesity and surgical weight loss on breast imaging, tissue, and cancer screening experience: the B-BRITE study.| | View in PubMed
- 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression.| | View in PubMed
- HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.| | View in PubMed
- Abstract HER2-14: HER2-14 HER-2 low status in early stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.| | View in PubMed
- Abstract P2-03-16: Quantifying estrogen and progesterone receptor status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.| | View in PubMed
- Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP).| | View in PubMed
- Abstract P6-05-10: An international survey on invasive lobular breast cancer (ILC) reveals gaps in knowledge and top priority research areas.| | View in PubMed
- Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival.| | View in PubMed
- Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.| | View in PubMed
- Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes.| | View in PubMed
- Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.| | View in PubMed
- Implementation, evaluation, and modification of a near-peer learning group in graduate surgical education.| | View in PubMed
- ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.| | View in PubMed
- Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.| | View in PubMed
- Hereditary vs Sporadic Invasive Lobular Carcinoma and Impact of Locoregional Therapy on Disease-Free Survival.| | View in PubMed
- Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.| | View in PubMed
- See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency.| | View in PubMed
- The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.| | View in PubMed
- ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.| | View in PubMed
- Abstract LB021: Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer progression.| | View in PubMed
- Pathologic complete response (pCR) rates for HR+/HER2- breast cancer by molecular subtype in the I-SPY2 Trial.| | View in PubMed
- Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-Reply.| | View in PubMed
- Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership.| | View in PubMed
- Abstract OT1-10-02: I-SPY2 endocrine optimization protocol (EOP): A pilot neoadjuvant endocrine therapy study with amcenestrant as monotherapy or in combination with abemacicilib or letrozole in molecularly selected HR+/HER2- clinical stage 2/3 breast can| | View in PubMed
- Abstract P2-02-02: Differences in levels of circulating tumor cells (CTC) and disseminated tumor cells (DTC) in early-stage lobular versus ductal breast cancer.| | View in PubMed
- Abstract P3-02-01: Initial experience of FES-dedicated breast PET imaging of early-stage ER+ invasive lobular carcinoma.| | View in PubMed
- Abstract P3-02-02: FES-dedicated breast PET uptake in early-stage ER+ breast cancers.| | View in PubMed
- Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL.| | View in PubMed
- The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study.| | View in PubMed
- O13 BIOLOGIC VERSUS SYNTHETIC MESH IN VENTRAL HERNIA REPAIR: PARTICIPANT-LEVEL ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS AT ONE YEAR.| | View in PubMed
- Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.| | View in PubMed
- Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?| | View in PubMed
- Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.| | View in PubMed
- Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief.| | View in PubMed
- Correction to: Applications of 3D printing in breast cancer management.| | View in PubMed
- Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.| | View in PubMed
- Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials.| | View in PubMed
- Early onset, multiple, bilateral fibroadenomas of the breast: a case report.| | View in PubMed
- Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions.| | View in PubMed
- Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.| | View in PubMed
- Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors.| | View in PubMed
- ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.| | View in PubMed
- Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).| | View in PubMed
- Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma.| | View in PubMed
- Abstract PD5-01: Magnetic resonance imaging insights from an active surveillance cohort of women with DCIS.| | View in PubMed
- Abstract PD6-08: DCE-MRI derived imaging features for characterizing invasive lobular breast cancer and predicting recurrence-free survival after neoadjuvant therapy.| | View in PubMed
- Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up.| | View in PubMed
- Abstract PS17-05: Relationship between body mass index and tumor subtype by menopausal status: An analysis in women with lobular carcinoma of the breast.| | View in PubMed
- Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.| | View in PubMed
- Applications of 3D printing in breast cancer management.| | View in PubMed
- A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines.| | View in PubMed
- Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.| | View in PubMed
- Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.| | View in PubMed
- Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.| | View in PubMed
- 274 Poster Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials.| | View in PubMed
- Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast.| | View in PubMed
- Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.| | View in PubMed
- Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.| | View in PubMed
- 4314 The Impact of Axillary Surgery on Recurrence-Free Survival in Invasive Lobular Carcinoma (ILC) of the Breast.| | View in PubMed
- Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast.| | View in PubMed
- Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.| | View in PubMed
- Abstract P3-08-16: The impact of residual ductal carcinoma in situ on breast cancer recurrence in the neoadjuvant I-SPY2 TRIAL.| | View in PubMed
- Abstract P4-13-01: Trends in primary management of invasive lobular carcinoma: An analysis of the National Cancer Database (NCDB).| | View in PubMed
- Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study.| | View in PubMed
- Abstract P6-16-06: Improved early stratification of invasive cancer risk using MRI in a ductal carcinoma in-situ short-term active surveillance cohort treated with neoadjuvant endocrine therapy.| | View in PubMed
- Abstract PD9-08: Accuracy of ultrasound in evaluating response to neoadjuvant therapy in invasive lobular carcinoma of the breast.| | View in PubMed
- Pragmatic Trials and Approaches to Transforming Care.| | View in PubMed
- Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.| | View in PubMed
- Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.| | View in PubMed
- Editorial: Applying Margin Consensus Guidelines to Invasive Lobular Carcinoma of the Breast.| | View in PubMed
- Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.| | View in PubMed
- Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.| | View in PubMed
- Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications.| | View in PubMed
- Abstract 118: The Impact of Post-Operative Prophylactic Antibiotics in Immediate 2-Stage Prepectoral Breast Reconstruction.| | View in PubMed
- Changes in mammographic density following bariatric surgery.| | View in PubMed
- Abstract P1-15-15: Accuracy of MRI after neoadjuvant therapy for invasive lobular carcinoma of the breast.| | View in PubMed
- Abstract P4-11-01: A simple intervention for long-term relief of chronic post mastectomy pain.| | View in PubMed
- Abstract P6-01-04: Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.| | View in PubMed
- Abstract PD7-06: Molecular subtypes of invasive lobular breast cancer in the I-SPY2 TRIAL.| | View in PubMed
- Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.| | View in PubMed
- Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents.| | View in PubMed
- ASO Author Reflections: Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.| | View in PubMed
- Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.| | View in PubMed
- Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.| | View in PubMed
- 452 (PB-085) The impact of mitotic score versus pleomorphic subtype on disease free survival in invasive lobular carcinoma of the breast.| | View in PubMed
- Abstract P2-12-16: The use of oncoplastic surgical techniques to increase successful breast conservation in invasive lobular carcinoma of the breast.| | View in PubMed
- Abstract P5-12-04: The impact of bariatric surgery on mammographic breast density.| | View in PubMed
- Abstract P5-22-22: Breast tumor location in BRCA mutation carriers and implications for prevention.| | View in PubMed
- Breast tumor location in BRCA mutation carriers and implications for prevention.| | View in PubMed
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.| | View in PubMed
- The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.| | View in PubMed
- How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer.| | View in PubMed
- Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.| | View in PubMed
- Abstract PD1-5: Characterizing the Tumor Immune MicroEnvironment (TIME) in high-risk ductal carcinoma in situ.| | View in PubMed
- The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.| | View in PubMed
- Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).| | View in PubMed
- Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.| | View in PubMed
- Biology of breast cancer in Nigerian women: a pilot study.| | View in PubMed
- Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.| | View in PubMed
- P1-06-10: Lobular Breast Cancer and NAC: Combined Results from the NKI and I-SPY 1 Trial.| | View in PubMed
- P4-09-19: PCNA+ Tumor Associated Macrophages Are Associated with M1 and M2 Gene Expression, and Confer Poor Prognosis in the Absence of Anti-Tumor Immune Environment.| | View in PubMed
- PD02-05: MRI Phenotype and Tumor Subtype Affect Breast Conservation Eligibility and MRI Accuracy in the I-SPY 1 Trial.| | View in PubMed
- Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.| | View in PubMed
- Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness.| | View in PubMed
- Benign Thoracic Disease in the Elderly.| | View in PubMed
- Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.| | View in PubMed
- Abstract P2-09-11: Response of Invasive Lobular Cancers to Neoadjuvant Therapy.| | View in PubMed
- Evaluation of levels of proliferating macrophages in patients at a county hospital and those with early recurrences.| | View in PubMed
- Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence.| | View in PubMed
- Bacteriologic features of surgical site infections following breast surgery.| | View in PubMed
- Benign thoracic disease in the elderly.| | View in PubMed
- Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.| | View in PubMed
- Image of the month--quiz case. Traumatic intramuscular cyst of the duodenum.| | View in PubMed
- Quality-of-life issues in psoriasis.| | View in PubMed